QuidelOrtho reported total revenue of $724 million for Q4 2025, with non-respiratory revenue growing 7% in constant currency and Labs revenue growing 8%. The company achieved an adjusted EBITDA margin of 21% and adjusted diluted EPS of $0.46. For the full year 2025, total revenue was $2.73 billion, with an adjusted EBITDA of $597 million.